Login
Tectonic Therapeutic Inc logo

Tectonic Therapeutic Inc

tectonictx.com

Tectonic Therapeutic Inc (NASDAQ: TECX) is a clinical-stage biopharmaceutical company. The filing excerpts provided do not contain sufficient detail to describe its core business activity, revenue model, competitive position, or key products beyond boilerplate forward-looking statement disclaimers and trademark disclosures. No revenue figures, pipeline descriptions, therapeutic area details, customer information, or competitive data are present in the supplied excerpts. Accordingly, a fully grounded canonical description cannot be constructed from this source material alone.

Financial Snapshot

Revenue
TTM
$0.00
Gross Margin
Last 4 Quarters
N/A
Net Income
TTM
-$83.43M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
1851.3%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
230.4M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$65.61M

Stock Price

Loading...
Market Cap: $647.97 Million

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support